Advertisement

Journal of Neuro-Oncology

, Volume 128, Issue 2, pp 217–223 | Cite as

Phloretin induces cell cycle arrest and apoptosis of human glioblastoma cells through the generation of reactive oxygen species

  • Yuanyuan Liu
  • Chenghe Fan
  • Lv Pu
  • Cui Wei
  • Haiqiang Jin
  • Yuming Teng
  • Mingming Zhao
  • Albert Cheung Hoi Yu
  • Feng Jiang
  • Junlong Shu
  • Fan Li
  • Qing Peng
  • Jian Kong
  • Bing Pan
  • Lemin Zheng
  • Yining Huang
Laboratory Investigation

Abstract

Phloretin, a flavonoid present in various plants, has been reported to exert anticarcinogenic effects. However, the mechanism of its chemo-preventive effect on human glioblastoma cells is not fully understood. This study aimed to investigate the molecular mechanism of phloretin and its associated chemo-preventive effect in human glioblastoma cells. The results indicate that phloretin inhibited cell proliferation by inducing cell cycle arrest at the G0–G1 phase and induced apoptosis of human glioblastoma cells. Phloretin-induced cell cycle arrest was associated with increased expression of p27 and decreased expression of cdk2, cdk4, cdk6, cyclinD and cyclinE. Moreover, the PI3K/AKT/mTOR signaling cascades were suppressed by phloretin in a dose-dependent manner. In addition, phloretin triggered the mitochondrial apoptosis pathway and generated reactive oxygen species (ROS). This was accompanied by the up-regulation of Bax, Bak and c-PARP and the down-regulation of Bcl-2. The antioxidant agents N-acetyl-l-cysteine and glutathione weakened the effect of phloretin on glioblastoma cells. In conclusion, these results demonstrate that phloretin exerts potent chemo-preventive activity in human glioblastoma cells through the generation of ROS.

Keywords

Phloretin Cell cycle arrest Apoptosis Reactive oxygen species Glioblastoma 

Notes

Acknowledgments

This study was funded by Grant 2012ZX09303-005-003 from the National S&T Major Project of China, Grant 2011CB503900 from the “973” National S&T Major Project, Grants 81370235 and 81170101 from the National Natural Science Foundation of China, and Grant 7122106 from the Natural Science Foundation of Beijing.

Compliance with ethical standards

Conflict of interest

None declared.

Supplementary material

11060_2016_2107_MOESM1_ESM.docx (27 kb)
Supplementary material 1 (DOCX 27 kb)

References

  1. 1.
    Wen PY, Kesari S (2008) Malignant gliomas in adults. New Engl J Med 359:492–507. doi: 10.1056/NEJMra0708126 CrossRefPubMedGoogle Scholar
  2. 2.
    Butler MS, Robertson AA, Cooper MA (2014) Natural product and natural product derived drugs in clinical trials. Nat Product Rep 31:1612–1661. doi: 10.1039/c4np00064a CrossRefGoogle Scholar
  3. 3.
    Byun S, Lee KW, Jung SK, Lee EJ, Hwang MK, Lim SH, Bode AM, Lee HJ, Dong Z (2010) Luteolin inhibits protein kinase C(epsilon) and c-Src activities and UVB-induced skin cancer. Cancer Res 70:2415–2423. doi: 10.1158/0008-5472.can-09-4093 CrossRefPubMedGoogle Scholar
  4. 4.
    Gao X, Wang B, Wei X, Men K, Zheng F, Zhou Y, Zheng Y, Gou M, Huang M, Guo G, Huang N, Qian Z, Wei Y (2012) Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale 4:7021–7030. doi: 10.1039/c2nr32181e CrossRefPubMedGoogle Scholar
  5. 5.
    Wang Y, Han E, Xing Q, Yan J, Arrington A, Wang C, Tully D, Kowolik CM, Lu DM, Frankel PH, Zhai J, Wen W, Horne D, Yip ML, Yim JH (2015) Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells. Cancer Lett 358:170–179. doi: 10.1016/j.canlet.2014.12.033 CrossRefPubMedGoogle Scholar
  6. 6.
    Park SY, Kim EJ, Shin HK, Kwon DY, Kim MS, Surh YJ, Park JH (2007) Induction of apoptosis in HT-29 colon cancer cells by phloretin. J Med Food 10:581–586. doi: 10.1089/jmf.2007.116 CrossRefPubMedGoogle Scholar
  7. 7.
    Shin JW, Kundu JK, Surh YJ (2012) Phloretin inhibits phorbol ester-induced tumor promotion and expression of cyclooxygenase-2 in mouse skin: extracellular signal-regulated kinase and nuclear factor-kappaB as potential targets. J Med Food 15:253–257. doi: 10.1089/jmf.2011.1851 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Yang KC, Tsai CY, Wang YJ, Wei PL, Lee CH, Chen JH, Wu CH, Ho YS (2009) Apple polyphenol phloretin potentiates the anticancer actions of paclitaxel through induction of apoptosis in human hep G2 cells. Mol Carcinog 48:420–431. doi: 10.1002/mc.20480 CrossRefPubMedGoogle Scholar
  9. 9.
    Polivka J Jr, Janku F (2014) Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther 142:164–175. doi: 10.1016/j.pharmthera.2013.12.004 CrossRefPubMedGoogle Scholar
  10. 10.
    Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP (1999) Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99:323–334CrossRefPubMedGoogle Scholar
  11. 11.
    Li Z, Li Q, Sun CX, Hertz L, Yu AC (2001) Cloning and identification of differentially expressed transcripts in primary culture of GABAergic neurons. Neurochem Res 26:1101–1105CrossRefPubMedGoogle Scholar
  12. 12.
    Chen XQ, Fung YW, Yu AC (2005) Association of 14-3-3gamma and phosphorylated bad attenuates injury in ischemic astrocytes. J Cereb Blood Flow Metabol 25:338–347. doi: 10.1038/sj.jcbfm.9600032 CrossRefGoogle Scholar
  13. 13.
    vom Dahl S, Haussinger D (1997) Evidence for a phloretin-sensitive glycerol transport mechanism in the perfused rat liver. Am J Physiol 272:G563–G574PubMedGoogle Scholar
  14. 14.
    vom Dahl S, Haussinger D (1996) Characterization of phloretin-sensitive urea export from the perfused rat liver. Bio Chem Hoppe-Seyler 377:25–37CrossRefGoogle Scholar
  15. 15.
    Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770–776. doi: 10.1038/35037710 CrossRefPubMedGoogle Scholar
  16. 16.
    Gogvadze V, Orrenius S (2006) Mitochondrial regulation of apoptotic cell death. Chem Biol Interact 163:4–14. doi: 10.1016/j.cbi.2006.04.010 CrossRefPubMedGoogle Scholar
  17. 17.
    Biswas R, Ahn JC, Kim JS (2015) Sulforaphene synergistically sensitizes cisplatin via enhanced mitochondrial dysfunction and PI3K/PTEN modulation in ovarian cancer cells. Anticancer Res 35:3901–3908PubMedGoogle Scholar
  18. 18.
    Rana C, Piplani H, Vaish V, Nehru B, Sanyal SN (2015) Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer. Mol Cell Biochem 402:225–241. doi: 10.1007/s11010-015-2330-5 CrossRefPubMedGoogle Scholar
  19. 19.
    Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25:55–57. doi: 10.1038/75596 CrossRefPubMedGoogle Scholar
  20. 20.
    Moon SK, Kim HM, Kim CH (2004) PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-kappaB and AP-1 in vascular smooth muscle cells. Arch Biochem Biophys 421:267–276CrossRefPubMedGoogle Scholar
  21. 21.
    Sherr CJ (1993) Mammalian G1 cyclins. Cell 73:1059–1065CrossRefPubMedGoogle Scholar
  22. 22.
    Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilcyznski S et al (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 55:2266–2269PubMedGoogle Scholar
  23. 23.
    Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O’Keefe CL, Matera AG, Xiong Y (1994) Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8:2939–2952CrossRefPubMedGoogle Scholar
  24. 24.
    Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66CrossRefPubMedGoogle Scholar
  25. 25.
    Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67–74CrossRefPubMedGoogle Scholar
  26. 26.
    Jordan NJ, Holman GD (1992) Photolabelling of the liver-type glucose-transporter isoform GLUT2 with an azitrifluoroethylbenzoyl-substituted bis-D-mannose. Biochem J 286(Pt 2):649–656CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Kern M, Pahlke G, Balavenkatraman KK, Bohmer FD, Marko D (2007) Apple polyphenols affect protein kinase C activity and the onset of apoptosis in human colon carcinoma cells. J Agric Food Chem 55:4999–5006. doi: 10.1021/jf063158x CrossRefPubMedGoogle Scholar
  28. 28.
    Miksicek RJ (1994) Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 49:153–160CrossRefPubMedGoogle Scholar
  29. 29.
    Kobori M, Shinmoto H, Tsushida T, Shinohara K (1997) Phloretin-induced apoptosis in B16 melanoma 4A5 cells by inhibition of glucose transmembrane transport. Cancer Lett 119:207–212CrossRefPubMedGoogle Scholar
  30. 30.
    Zhu BH, Yao ZX, Luo SJ, Jiang LM, Xiao JW, Liu SC, Liu JB, Sun JM, Pei ZY (2005) Effects of antisense oligonucleotides of PKC-alpha on proliferation and apoptosis of HepG2 in vitro. Hepat Pancreat Dis Intern 4:75–79Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Yuanyuan Liu
    • 1
  • Chenghe Fan
    • 1
  • Lv Pu
    • 1
  • Cui Wei
    • 1
  • Haiqiang Jin
    • 1
  • Yuming Teng
    • 1
  • Mingming Zhao
    • 2
  • Albert Cheung Hoi Yu
    • 3
    • 4
  • Feng Jiang
    • 3
    • 4
  • Junlong Shu
    • 1
  • Fan Li
    • 1
  • Qing Peng
    • 1
  • Jian Kong
    • 5
  • Bing Pan
    • 2
  • Lemin Zheng
    • 2
  • Yining Huang
    • 1
  1. 1.Department of NeurologyPeking University First HospitalBeijingChina
  2. 2.The Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, and Key Laboratory of Molecular Cardiovascular Sciences of Ministry of EducationPeking University Health Science CenterBeijingChina
  3. 3.Key Laboratory of Neuroscience, Neurosciences Research InstitutePeking UniversityBeijingChina
  4. 4.Department of NeurobiologyPeking University Health Science CenterBeijingChina
  5. 5.Department of Hepatobiliary Surgery, Beijing Chao-yang HospitalCapital Medical UniversityBeijingChina

Personalised recommendations